Literature DB >> 8351019

Effect of cranial irradiation on seizure frequency in adults with low-grade astrocytoma and medically intractable epilepsy.

L R Rogers1, H H Morris, K Lupica.   

Abstract

We report the effect of cranial irradiation on seizure frequency in five adults with unresected (biopsy-proven) cerebral hemisphere low-grade astrocytoma and medically intractable epilepsy. Seizures were refractory to standard antiepileptic drugs for 7 months to 27 years. Treatment with 5,400 cGy to 6,120 cGy focal radiation reduced seizure frequency by more than 90% in three patients (one of whom became seizure-free) and by more than 75% (but less than 90%) in one patient. One patient had no response. Brain CT or MRI showed a partial tumor response to radiation in three of the four patients with reduced seizure frequency. In three patients, the reduced seizure frequency continued to the most recent follow-up of 1 to 1.5 years. In the patient who became seizure-free, seizures recurred at 8.2 years and were associated with tumor progression. Irradiation can reduce seizure frequency in some patients with unresected cerebral hemisphere low-grade astrocytoma and medically intractable epilepsy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8351019     DOI: 10.1212/wnl.43.8.1599

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Antiepileptic therapy in patients with central nervous system malignancies.

Authors:  Glen H J Stevens
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 2.  Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review.

Authors:  Johan A F Koekkoek; Melissa Kerkhof; Linda Dirven; Jan J Heimans; Jaap C Reijneveld; Martin J B Taphoorn
Journal:  Neuro Oncol       Date:  2015-03-25       Impact factor: 12.300

Review 3.  Seizures and epilepsy in cancer patients.

Authors:  Edward K Avila; Jerome Graber
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

Review 4.  Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.

Authors:  J Manuel Sarmiento; Andrew S Venteicher; Chirag G Patil
Journal:  Cochrane Database Syst Rev       Date:  2015-06-29

Review 5.  Medical management of brain tumors and the sequelae of treatment.

Authors:  David Schiff; Eudocia Q Lee; Lakshmi Nayak; Andrew D Norden; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-10-30       Impact factor: 12.300

Review 6.  Neurocognitive functioning in adult WHO grade II gliomas: impact of old and new treatment modalities.

Authors:  Martin Klein
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 7.  Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments.

Authors:  Roberta Rudà; Lorenzo Bello; Hugues Duffau; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

Review 8.  Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials.

Authors:  Edward K Avila; Marc Chamberlain; David Schiff; Jaap C Reijneveld; Terri S Armstrong; Roberta Ruda; Patrick Y Wen; Michael Weller; Johan A F Koekkoek; Sandeep Mittal; Yoshiki Arakawa; Ali Choucair; Jorge Gonzalez-Martinez; David R MacDonald; Ryo Nishikawa; Aashit Shah; Charles J Vecht; Paula Warren; Martin J van den Bent; Lisa M DeAngelis
Journal:  Neuro Oncol       Date:  2016-09-20       Impact factor: 12.300

9.  Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study.

Authors:  Roberta Rudà; Umberto Magliola; Luca Bertero; Elisa Trevisan; Chiara Bosa; Cristina Mantovani; Umberto Ricardi; Anna Castiglione; Chiara Monagheddu; Riccardo Soffietti
Journal:  Neuro Oncol       Date:  2013-07-28       Impact factor: 12.300

Review 10.  Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy.

Authors:  Terri S Armstrong; Robin Grant; Mark R Gilbert; Jong Woo Lee; Andrew D Norden
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.